Winter blood pressure fluctuations are repeated, and there are new ways to manage cardiovascular disease

Science and Technology Daily News On December 16, the 23rd National Cardiovascular Annual Conference of the Chinese Medical Association and the 12th Straits Cardiovascular Disease Summit Forum sponsored by the Chinese Medical Association and the Cardiovascular Disease Branch of the Chinese Medical Association were held in Xiamen, and many representatives of cardiovascular experts and relevant professionals from all over the country attended the meeting to discuss the prevention, treatment and latest scientific research progress and achievements of cardiovascular diseases in China. At the same time, it is the deep winter season, the risk of cardiovascular events is high, taking this opportunity of the annual meeting, the Affiliated Cardiovascular Disease Hospital of Xiamen University carried out a large-scale cardiovascular health consultation activity on the 16th, and dozens of authoritative experts in the cardiovascular field participated in the activity, providing scientific and professional prevention and treatment guidance for more than 100 patients to popularize cardiovascular disease knowledge, answer difficult questions, provide scientific and professional prevention and treatment guidance, help them rationally use intelligent management methods, achieve long-term standardized treatment, and reduce the risk of cardiovascular events.

(Dozens of national cardiovascular experts jointly conduct cardiovascular health consultation activities)

Experts in the field of cardiovascular diseases have difficult questions and call for attention to the whole process of cardiovascular disease management

In recent years, the prevalence of cardiovascular diseases in China has continued to rise, and it is estimated that the number of patients is as high as 330 million. At the same time, as a big country with high blood pressure, the prevalence of hypertension in China is not optimistic, about 245 million adults have hypertension, and almost every family has hypertension in the family unit. Hypertension is one of the common risk factors for causing cardiovascular and cerebrovascular adverse events and even death, which will not only bring symptoms such as headache, dizziness and tinnitus, but also damage to the heart, brain, kidney and blood vessels throughout the body, thereby increasing the risk of serious adverse events of cardiovascular and cerebrovascular diseases.

In addition, whenever winter comes, the temperature plummets, and the recurrence of high blood pressure is particularly obvious. Because of the large temperature difference between morning and evening, the temperature change of one cold and one hot can easily lead to vasospasm, large fluctuations in blood pressure, and increase the risk of morning cerebral hemorrhage or nocturnal cerebral ischemia. The annual meeting was held in the winter, many experts in the field of cardiovascular disease gathered in Xiamen Hospital for health consultation for more than 100 patients, Professor Dai Cuilian of the Affiliated Cardiovascular Hospital of Xiamen University said: "Winter is the season of high incidence of hypertension, blood pressure is suddenly high and low, and it is difficult to control. In addition, there are many patients with hypertension who will have a variety of chronic diseases, and take a variety of drugs at the same time in winter, which also has a certain impact on blood pressure values. In order to cope with the fluctuation of blood pressure in winter patients and the challenge of hypertensive disease management, patients are reminded not to adjust drugs or stop drugs without authorization, and at the same time, on the basis of blood pressure reduction, we must pay more attention to the damage of diseases to heart, brain, kidneys and other organs. Pay equal attention to blood pressure reduction and protection, and carry out the whole process of disease management from hypertension, a high risk factor in the early stage of cardiovascular disease, to heart failure at the end of cardiovascular disease. At the same time, patients can also rationally use the intelligent disease management platform for home cardiovascular disease management. ”

Dai Cuilian also added: "In terms of innovative drugs, with the dynamic adjustment of the national medical insurance catalogue, patients with hypertension can quickly use international advanced treatment drugs within the scope of medical insurance reimbursement. Just in early December, the National Medical Security Bureau announced the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalogue (2021)", as the only innovative drug that can cover hypertension to heart failure, Shakuba Trisacsartan is also among them, which can protect organs such as heart, kidney and blood vessels while reducing blood pressure, thereby blocking the cardiovascular event chain in multiple ways. ”

The innovative technology platform intelligently manages chronic diseases, and "cares for the heart" to protect the health of patients

In this health consultation activity, in order to help patients with chronic diseases to better manage diseases at home, many experts suggest that patients can use the innovative intelligent disease management platform for convenient long-term management. The artificial intelligence disease management platform for the full-line management of cardiovascular diseases, "Care for the Heart", relies on the WeChat Mini Program as the carrier, with daily indicator monitoring, health status assessment, personalized information and other core functions, to help cardiovascular disease patients achieve more intimate and convenient disease self-management, and reduce the heavy burden caused by repeated admissions.

Dai Cuilian introduced: "The core value of 'Care for the Heart' lies in optimizing the traditional medical model of the hospital, helping doctors to grasp the patient's condition in a timely manner, assisting patients outside the hospital to manage the whole process of disease, and meeting the health needs of each family." With the continuous innovation of technical means, our doctors hope that the majority of patients can change the concept of treatment, more convenient and more active to carry out their own disease management, but also through a more convenient, multi-channel mode to enjoy professional treatment and disease science, through the application of artificial intelligence technology, give play to the power of digitalization, open up the barrier of hospital management and home management, effectively benefit a wider range of patient groups, help them manage cardiovascular health throughout the process, improve prognosis. ”

As the country's first out-of-hospital chronic disease management project, the intelligent management platform "Little Love for the Heart" has been officially launched since July 2020, helping heart failure patients to achieve self-management of out-of-hospital diseases and enhance disease awareness and management awareness. In 2021, the "Little Love for the Heart" will be comprehensively upgraded, expanding the management field from heart failure to the whole line of cardiovascular, providing one-stop service for personalized disease management for the majority of cardiovascular patients, further strengthening cardiovascular health education, and promoting the rapid development of digital chronic disease management. It has reached more than 200,000 patients with cardiovascular diseases.